查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760979

全球神經血管設備/介入性神經學市場

Neurovascular Devices / Interventional Neurology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球神經血管設備/介入性神經學市場規模將達到 61 億美元

全球神經血管器械/介入神經病學市場規模預計在2024年為40億美元，預計到2030年將達到61億美元，在2024-2030年的分析期內，複合年成長率為7.3%。動脈瘤栓塞和栓塞器械是本報告分析的細分市場之一，預計其複合年成長率為8.2%，到分析期結束時規模將達到27億美元。神經血栓切除器械細分市場在分析期間的複合年成長率預計為6.5%。

美國市場預計將達到 11 億美元，中國市場複合年成長率將達到 6.9%

預計2024年美國神經血管器械/介入性神經病學市場規模將達11億美元。作為世界第二大經濟體的中國，預計到2030年市場規模將達到9.386億美元，在2024-2030年的分析期內，複合年成長率為6.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.9%和5.7%。在歐洲，預計德國市場的複合年成長率為5.8%。

全球神經血管設備/介入性神經學市場—主要趨勢與促進因素摘要

什麼是神經血管裝置？為什麼它們在神經病學中很重要？

神經血管器械是用於治療影響腦部和脊椎血管疾病的醫療器械。這些器械在治療中風、動脈瘤、動靜脈畸形 (AVM) 和其他中樞神經系統血管異常等手術中至關重要。此類產品包括栓塞線圈、神經血管支架、血栓切除裝置和導管等，使介入神經科醫生能夠實施微創手術，以恢復正常血流並降低出血和缺血風險。

隨著介入性神經病學（一個專注於利用神經血管器械治療腦血管疾病的領域）的興起，神經血管器械的重要性呈指數級成長。中風是全球死亡和致殘的主要原因之一，也是利用神經血管器械治療的主要疾病。與傳統的開放性手術相比，微創神經血管介入治療具有顯著優勢，包括恢復時間更快、併發症風險更低以及成功率更高。隨著全球中風和動脈瘤負擔的日益加重，神經血管器械在挽救患者生命和改善預後方面發揮關鍵作用。

神經血管裝置市場如何發展？

由於技術進步和人們對微創手術的日益偏好，神經血管器械市場正在快速發展。影響市場的主要趨勢之一是用於清除缺血性中風患者血栓的下一代血栓切除器械的開發。這些器械正在不斷進行技術創新，其設計經過改進，可以更快、更有效地清除血栓，從而縮短從中風發作到治療的時間，並改善患者的預後。機械血栓切除術目前被認為是急性缺血性腦中風的黃金標準，導致這些器械的需求激增。

另一個主要趨勢是，擴大使用導流器來治療複雜的腦動脈瘤。導流器類似於支架，旨在將血流從動脈瘤轉移，促進血管癒合並防止破裂。對於大型或難以觸及的動脈瘤，這些裝置提供了比傳統栓塞術侵入性更小、更有效的替代方案。此外，市場對神經血管通路產品（例如導管導引線和微導管）的需求也在不斷成長，這些產品對於將治療器械精準輸送到腦部至關重要。

哪些條件推動了神經血管裝置的採用？

多種疾病促使神經血管裝置的應用日益廣泛，其中中風尤為重要。中風，尤其是由血栓引起的缺血性中風，需要立即介入以恢復血流並防止永久性腦損傷。血栓摘取支架和抽吸導管等神經血管裝置對於這些挽救生命的手術至關重要。由血管破裂引起的出血性中風也需要使用動脈瘤夾、彈簧圈和血流轉向器等裝置來防止進一步出血並穩定患者病情。

動脈瘤是另一個主要誘因，因為動脈瘤一旦破裂，可能導致危及生命的出血。使用栓塞線圈和血流轉向器等裝置進行微創干預，可以對動脈瘤標靶治療，而無需進行開放性手術。腦動靜脈畸形 (AVM) 和硬腦膜動靜脈瘻管 (DAVF)（腦內動脈和靜脈之間的異常連接）也可使用神經血管裝置進行治療。這些疾病通常需要栓塞治療或手術切除術，這兩種方法都需要專門的器械來降低破裂和出血的風險。

推動神經血管設備市場成長的關鍵因素是什麼？

神經血管器械市場的成長受多種關鍵因素驅動。全球中風和腦動脈瘤盛行率的上升是主要促進因素，尤其是在人口老化加劇這些疾病風險的情況下。另一個關鍵因素是對微創外科手術的需求不斷成長，這些手術可以縮短患者的康復時間、縮短住院時間並降低併發症率。隨著介入神經病學的不斷發展，對血栓切除系統、支架和栓塞產品等尖端設備的需求也日益成長。

神經血管器械的技術進步也推動了市場的成長。新一代血栓切除器械、血流轉向器和栓塞線圈的研發，提高了精準度和安全性，並擴大了可治療疾病的範圍。此外，醫療基礎設施投資的增加，尤其是在新興市場，正在提升神經血管治療的可近性。政府致力於降低中風相關死亡率並改善預後，加之人們對中風預防和早期治療的認知不斷提高，也促進了市場的擴張。

部分

產品類型（動脈瘤栓塞及栓塞裝置、神經血栓切除裝置、腦球囊血管成形術及支架系統、支持裝置）、疾病狀況（腦動脈瘤、缺血性中風、動靜脈畸形及瘻管、其他疾病狀況）、最終用戶（醫院、門診手術中心、其他最終用戶）

受訪企業範例（共12家值得關注的企業）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13584

Global Neurovascular Devices / Interventional Neurology Market to Reach US$6.1 Billion by 2030

The global market for Neurovascular Devices / Interventional Neurology estimated at US$4.0 Billion in the year 2024, is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Neurothrombectomy Devices segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 6.9% CAGR

The Neurovascular Devices / Interventional Neurology market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$938.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Neurovascular Devices/Interventional Neurology Market - Key Trends & Drivers Summarized

What Are Neurovascular Devices and Why Are They Critical in Neurology?

Neurovascular devices are medical tools designed to treat disorders affecting the blood vessels in the brain and spine. These devices are essential for procedures like treating strokes, aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities in the central nervous system. The category includes products such as embolization coils, neurovascular stents, thrombectomy devices, and catheters, which allow interventional neurologists to perform minimally invasive procedures to restore normal blood flow and reduce the risk of hemorrhage or ischemia.

The importance of neurovascular devices has grown exponentially with the rise of interventional neurology, a field that focuses on using these devices to treat cerebrovascular diseases. Stroke, one of the leading causes of death and disability worldwide, is a primary condition treated with these tools. Minimally invasive neurovascular interventions offer significant advantages, such as faster recovery times, reduced risk of complications, and higher success rates compared to traditional open-brain surgery. As the global burden of stroke and aneurysms rises, neurovascular devices play a critical role in saving lives and improving outcomes for patients.

How Is the Neurovascular Devices Market Evolving?

The neurovascular devices market is evolving rapidly due to advances in technology and the growing preference for minimally invasive procedures. One of the key trends shaping the market is the development of next-generation thrombectomy devices, which are used to remove blood clots in patients with ischemic stroke. These devices have seen continuous innovation, with improvements in their design allowing for faster and more effective clot removal, which in turn reduces the time between stroke onset and treatment, improving patient outcomes. Mechanical thrombectomy is now considered the gold standard for acute ischemic stroke, leading to a surge in demand for these devices.

Another significant trend is the increasing use of flow diverters for the treatment of complex brain aneurysms. Flow diverters are stent-like devices designed to redirect blood flow away from an aneurysm, promoting healing of the vessel and preventing rupture. These devices offer a less invasive and more effective alternative to traditional coiling procedures for large or difficult-to-reach aneurysms. Additionally, the market is witnessing growth in demand for neurovascular access products such as guidewires and microcatheters, which are critical for delivering therapeutic devices to the brain with precision.

Which Conditions Are Driving the Adoption of Neurovascular Devices?

Several conditions are driving the increased adoption of neurovascular devices, with stroke being the most significant. Strokes, particularly ischemic strokes caused by blood clots, require immediate intervention to restore blood flow and prevent permanent brain damage. Neurovascular devices, such as stent retrievers and aspiration catheters, are essential for these life-saving procedures. Hemorrhagic strokes, which result from ruptured blood vessels, also demand the use of devices like aneurysm clips, coils, and flow diverters to prevent further bleeding and stabilize the patient.

Aneurysms are another major driver, as they can lead to life-threatening bleeding if they rupture. Minimally invasive interventions using devices like embolization coils or flow diverters allow for targeted treatment of aneurysms without the need for open surgery. Arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs), which are abnormal connections between arteries and veins in the brain, are also treated using neurovascular devices. These conditions often require embolization or surgical resection, both of which rely on specialized tools to reduce the risk of rupture and bleeding.

What Are the Key Growth Drivers in the Neurovascular Devices Market?

The growth in the neurovascular devices market is driven by several key factors. The increasing prevalence of stroke and brain aneurysms globally is a major driver, particularly as aging populations face a higher risk of these conditions. Another critical factor is the growing demand for minimally invasive surgical procedures, which offer patients faster recovery times, reduced hospital stays, and lower rates of complications. As interventional neurology continues to advance, the demand for cutting-edge devices such as thrombectomy systems, stents, and embolization products is rising.

Technological advancements in neurovascular devices are also fueling market growth. The development of next-generation thrombectomy devices, flow diverters, and embolization coils with enhanced precision and safety features is expanding the range of treatable conditions. In addition, the increasing investments in healthcare infrastructure, especially in emerging markets, are boosting access to neurovascular treatments. Government initiatives focused on reducing stroke-related mortality and improving outcomes are also contributing to the market’s expansion, along with rising awareness of stroke prevention and early treatment.

SCOPE OF STUDY:

The report analyzes the Neurovascular Devices / Interventional Neurology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices); Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, Other Disease Pathologies); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Neurovascular Devices / Interventional Neurology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Neurovascular Disorders Drives Demand for Neurovascular Devices
    • Advancements in Minimally Invasive Interventional Neurology Techniques Propel Growth of Neurovascular Devices Market
    • Growing Use of Mechanical Thrombectomy Devices Strengthens Market for Ischemic Stroke Treatment
    • Increasing Adoption of Flow Diverters and Stents in Aneurysm Treatment Expands Market for Neurovascular Devices
    • Rising Demand for Embolization Coils in Brain Aneurysm and AVM Treatments Drives Market Growth
    • Advancements in Imaging Technologies and Real-Time Navigation Systems Propel Growth of Interventional Neurology Devices
    • Growing Focus on Minimally Invasive Clot Retrieval Expands Market for Aspiration Catheters in Stroke Intervention
    • Increasing Adoption of Neurovascular Devices in Treating Arteriovenous Malformations (AVMs) Expands Addressable Market
    • Emerging Focus on Liquid Embolics and Adhesives in Neurovascular Surgery Generates New Opportunities for Device Manufacturers
    • Technological Innovations in Neurovascular Stent Retrievers Strengthen the Business Case for Endovascular Stroke Treatment
    • Rising Prevalence of Aneurysms and Stroke in Aging Populations Propels Demand for Neurovascular Devices
    • Increasing Use of Balloon Catheters in Endovascular Procedures Drives Growth in Neurovascular Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Devices / Interventional Neurology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aneurysm Coiling & Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurothrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cerebral Aneurysms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ischemic Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Arteriovenous Malformation & Fistulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Disease Pathologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION